DE3855220T3 - Methode zur beseitigung von infektionserregern in geweben - Google Patents

Methode zur beseitigung von infektionserregern in geweben

Info

Publication number
DE3855220T3
DE3855220T3 DE3855220T DE3855220T DE3855220T3 DE 3855220 T3 DE3855220 T3 DE 3855220T3 DE 3855220 T DE3855220 T DE 3855220T DE 3855220 T DE3855220 T DE 3855220T DE 3855220 T3 DE3855220 T3 DE 3855220T3
Authority
DE
Germany
Prior art keywords
body tissues
resulting
tissues
effective
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3855220T
Other languages
English (en)
Other versions
DE3855220D1 (de
DE3855220T2 (de
Inventor
Millard Judy
James Matthews
Joseph Newnam
Franklin Sogandares-Bernal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor Research Institute
Original Assignee
Baylor Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3855220(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baylor Research Foundation filed Critical Baylor Research Foundation
Publication of DE3855220D1 publication Critical patent/DE3855220D1/de
Publication of DE3855220T2 publication Critical patent/DE3855220T2/de
Application granted granted Critical
Publication of DE3855220T3 publication Critical patent/DE3855220T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
DE3855220T 1987-06-25 1988-06-24 Methode zur beseitigung von infektionserregern in geweben Expired - Fee Related DE3855220T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/067,237 US4878891A (en) 1987-06-25 1987-06-25 Method for eradicating infectious biological contaminants in body tissues
PCT/US1988/002174 WO1988010087A1 (en) 1987-06-25 1988-06-24 Method for eradicating infectious contaminants in tissues

Publications (3)

Publication Number Publication Date
DE3855220D1 DE3855220D1 (de) 1996-05-23
DE3855220T2 DE3855220T2 (de) 1996-11-14
DE3855220T3 true DE3855220T3 (de) 2001-11-08

Family

ID=22074629

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3855220T Expired - Fee Related DE3855220T3 (de) 1987-06-25 1988-06-24 Methode zur beseitigung von infektionserregern in geweben

Country Status (8)

Country Link
US (2) US4878891A (de)
EP (1) EP0368902B2 (de)
JP (1) JP2930595B2 (de)
AT (1) ATE136753T1 (de)
AU (1) AU620556B2 (de)
CA (1) CA1294411C (de)
DE (1) DE3855220T3 (de)
WO (1) WO1988010087A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107320743B (zh) * 2017-05-22 2020-09-18 鸿利智汇集团股份有限公司 一种利用移动终端实现紫外杀菌方法及系统

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
EP0337598A3 (de) * 1988-02-26 1991-07-03 Georgia State University Foundation, Inc. Verwendung von Porphyrinen und Metalloporphyrinen zur Behandlung von durch HIV verursachten Krankheiten
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US5252720A (en) * 1989-03-06 1993-10-12 Board Of Regents, The University Of Texas System Metal complexes of water soluble texaphyrins
US5567687A (en) * 1989-03-06 1996-10-22 University Of Texas Texaphyrins and uses thereof
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5272142A (en) * 1989-03-06 1993-12-21 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5041078A (en) * 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5599923A (en) * 1989-03-06 1997-02-04 Board Of Regents, University Of Tx Texaphyrin metal complexes having improved functionalization
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US6348309B1 (en) * 1989-09-13 2002-02-19 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. Process for inactivating viruses in blood and blood products
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US5503721A (en) 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US5080645A (en) * 1989-10-31 1992-01-14 Hanig Joseph P Procedure for reducing the body burden of HIV (AIDS) and other blood borne infections
US5457195A (en) * 1989-12-21 1995-10-10 Board Of Regents, The University Of Texas System Sapphyrin derivatives and conjugates
US5594136A (en) * 1989-12-21 1997-01-14 Pharmacyclics, Inc. Texaphyrin solid supports and devices
US5543514A (en) * 1989-12-21 1996-08-06 Board Of Regents, The University Of Texas System Water-soluble sapphyrins
US5798238A (en) * 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
ATE232737T1 (de) * 1990-04-16 2003-03-15 Baxter Int Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US5955256A (en) * 1990-04-16 1999-09-21 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
ZA912842B (en) * 1990-04-16 1992-03-25 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5516629A (en) 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
AU7954691A (en) * 1990-05-01 1991-11-27 American National Red Cross, The Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
US5712086A (en) * 1990-05-15 1998-01-27 New York Blood Center, Inc. Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5981163A (en) 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
JP3051996B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するためのシステム
CA2075704A1 (en) * 1990-12-20 1992-06-21 Daniel F. Bischof Systems and methods eradicating contaminants in fluids
JP3051998B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 光活性療法及び細胞分離技術を用いる血液のような液体中の遊離の及び同伴された汚染物を同時に除去するためのシステム並びに方法
ZA919934B (en) * 1990-12-20 1992-09-30 Baxter Int Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation
US5587394A (en) * 1991-03-28 1996-12-24 The University Of Toledo Production and use of diels alder adducts of vinyl porphyrins, of metal complexes thereof, and of compositions containing such adducts and complexes
EP0544895B1 (de) * 1991-06-21 1997-08-27 Baxter International Inc. Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit
US5263925A (en) * 1991-07-22 1993-11-23 Gilmore Jr Thomas F Photopheresis blood treatment
US5595726A (en) * 1992-01-21 1997-01-21 Pharmacyclics, Inc. Chromophore probe for detection of nucleic acid
US5565552A (en) * 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5607924A (en) * 1992-01-21 1997-03-04 Pharmacyclics, Inc. DNA photocleavage using texaphyrins
US5888997A (en) * 1994-04-14 1999-03-30 Pharmacyclics, Inc. Radiation sensitization using texaphyrins
US5763172A (en) * 1992-01-21 1998-06-09 Board Of Regents, The University Of Texas System Method of phosphate ester hydrolysis
WO1996014740A1 (en) 1992-03-02 1996-05-23 Cerus Corporation Synthetic media for blood components
US6433343B1 (en) * 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5618662A (en) * 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
ES2147203T3 (es) * 1992-08-07 2000-09-01 Cerus Corp Procedimientos de inactivacion de bacterias en las preparaciones a base de sangre con la ayuda de 8-metoxipsoraleno.
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
FR2696756B1 (fr) * 1992-10-14 1994-12-30 American Cyanamid Co Utilisation de composés photosensibilisateurs de type chlorine dérivés de prophyrines vinyliques pour inactiver des virus.
PT947222E (pt) * 1992-11-20 2006-09-29 Univ British Columbia Metodo de activacao de agentes fotossensiveis
US6214033B1 (en) 1992-12-28 2001-04-10 Matsushita Electric Industrial Co., Ltd. Medical laser apparatus and diagnostic/treatment apparatus using the medical laser apparatus
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
WO1995000631A1 (en) * 1993-06-23 1995-01-05 New York Blood Center, Inc. System for viral inactivation of blood
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5712085A (en) 1993-06-28 1998-01-27 Cerus Corporation 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
ATE214542T1 (de) * 1993-07-12 2002-04-15 Baxter Int Apparatur und verfahren zur inaktivierung von viralen verunreinigungen in körperflüssigkeit
RU2118177C1 (ru) * 1993-08-02 1998-08-27 Алексей Борисович Башкиров Способ индукции иммунного ответа организма
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
US5474910A (en) * 1993-10-15 1995-12-12 Alfano; Robert R. Method and device for detecting biological molecules and/or microorganisms within a desired area or space
DE69432832T2 (de) * 1993-11-10 2004-05-06 Cerus Corp., Concord Vorrichtung und verfahren zur photoaktivierung
FR2712493B1 (fr) * 1993-11-16 1996-01-19 Centre Nat Rech Scient Utilisation de photosensibilisateurs dérivés du noyau phorbine pour la décontamination du sang infecté par des parasites et/ou des virus.
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
US5533964A (en) * 1994-02-17 1996-07-09 Rossmark Medical Publishers Inc. Apparatus for removal of excess hydrogen ions from humans
US6156028A (en) 1994-03-21 2000-12-05 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment of wounds
US5969111A (en) * 1994-04-14 1999-10-19 Board Of Regents, The University Of Texas System Texaphyrins substituted with imidazole are provided
FI942576A0 (fi) * 1994-06-01 1994-06-01 Suomen Punainen Risti Veripalv Behandling av plasma
WO1996005778A1 (en) * 1994-08-23 1996-02-29 Spinetech, Inc. Cervical spine stabilization system
US5762867A (en) * 1994-09-01 1998-06-09 Baxter International Inc. Apparatus and method for activating photoactive agents
US5837866A (en) * 1994-09-21 1998-11-17 Board Of Regents, The University Of Texas Phosphoramidite derivatives of macrocycles
US5633354A (en) * 1994-09-21 1997-05-27 Pharmacyclics, Inc. Phosphoramidite derivatives of texaphyrins
US5527704A (en) * 1994-12-06 1996-06-18 Baxter International Inc. Apparatus and method for inactivating viral contaminants in body fluids
CA2215978A1 (en) * 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
CA2174806A1 (en) * 1995-04-24 1996-10-25 Frank Sever Jr. Method and apparatus for enabling extracorporeal therapeutic treatment of a living patient's entire blood supply during a single uninterrupted time interval
US5756726A (en) * 1995-06-02 1998-05-26 Pharmacyclics, Inc. Methods of producing singlet oxygen using compounds having improved functionalization
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
WO1998006340A1 (en) * 1995-06-07 1998-02-19 Prescott Marvin A Method and apparatus for preventing adhesion and colonization of bacteria in medical devices
US6235508B1 (en) 1995-06-07 2001-05-22 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
ATE235814T1 (de) * 1995-11-06 2003-04-15 New York Blood Ct Inc Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht
WO1997036634A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of chronic hcv infections
BR9708468A (pt) * 1996-03-29 2000-01-04 Therakos Inc Tratamento de fotoferese de leucocitos.
JP2000508317A (ja) 1996-04-09 2000-07-04 セラコス・インコーポレイテッド 体液からプソラレンを除去する方法
US5702432A (en) * 1996-10-03 1997-12-30 Light Sciences Limited Partnership Intracorporeal light treatment of blood
US5922278A (en) * 1996-11-19 1999-07-13 Baxter International Inc. Method and apparatus for inactivating contaminants in biological fluid
US6190609B1 (en) 1996-11-19 2001-02-20 Baxter International Inc. Methods and apparatus for inactivating contaminants in biological fluid
IL119683A (en) 1996-11-25 2002-12-01 Rachel Lubart Method and device for light irradiation into tissue
DE19654266A1 (de) * 1996-12-23 1998-06-25 Albrecht Prof Dr Wendel Untersuchungsverfahren mit biologischem System
US6030767A (en) * 1997-01-21 2000-02-29 The American National Red Cross Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
US5843698A (en) * 1997-04-30 1998-12-01 Universal Ventures Deleteriously affecting members of a target species by exposure to a component of symbiont or food source of an adjoiner species that is symbiotic with the target species
JP4166432B2 (ja) * 1997-07-10 2008-10-15 セラコス・インコーポレイテッド 腸又は膀胱の炎症性疾病の処置
GB9721506D0 (en) * 1997-10-10 1997-12-10 Virulite Limited Treatment of diseases
DE69819360T2 (de) * 1997-11-20 2004-08-19 Cerus Corp., Concord Neue psoralene zur inaktivierung von pathogenen
CA2321995A1 (en) * 1998-02-26 1999-09-02 Eric Kin-Lam Lee Method and apparatus for irradiating a biological fluid
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6277337B1 (en) * 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US6610436B1 (en) * 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
US6117862A (en) 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
CA2358662A1 (en) * 1999-01-15 2000-07-20 James Chen Therapeutic compositions for metabolic bone disorders or bone metastases
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534218A (ja) 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US6074815A (en) * 1999-03-08 2000-06-13 Universal Ventures Selection of test species for testing to identify components thereof that deleteriously affect a target species member
US7445756B2 (en) * 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US7025877B1 (en) * 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
NZ517806A (en) * 1999-09-16 2003-09-26 Vasogen Ireland Ltd Apparatus and process for conditioning mammalian blood
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US20020049247A1 (en) 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
SE0000866L (sv) * 2000-03-16 2001-09-17 Peter Unger Med P U Med Konsul Metod och anordning för behandling av biologiskt material
US6793643B1 (en) 2000-04-21 2004-09-21 Therakos, Inc. Low extracorporeal volume treatment system
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US7381976B2 (en) 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
JP4647187B2 (ja) * 2001-04-02 2011-03-09 セルメド バイオサイエンシズ インコーポレイテッド ハロゲン化ローダミン誘導体およびその適用
HU224941B1 (en) * 2001-08-10 2006-04-28 Bgi Innovacios Kft Phototerapy apparatus
AU2002362766A1 (en) 2001-10-10 2003-04-22 Benbow Corporation Method and device for transporting equine semen
AU2003230553B2 (en) * 2002-02-22 2008-08-21 Intracel Resources Llc Sterile immunogenic non-tumorigenic tumor cell compositions and methods
EP1693072A1 (de) * 2002-04-26 2006-08-23 Gambro, Inc., Vorrichtung und Methode zur Bestrahlung und Mischung von Fluiden in Behältern
EP1501555B1 (de) * 2002-04-26 2007-02-21 Gambro, Inc., Vorrichtung zur bestrahlung und mischung von fluiden in behältern
WO2003103390A1 (en) * 2002-06-07 2003-12-18 Promethean Lifesciences, Inc. Sterilization, stabilization and preservation of functional biologics
WO2003105926A1 (en) * 2002-06-14 2003-12-24 Karp Nelson M Treatment of blood with light
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP2036908A3 (de) 2002-07-02 2009-05-13 Health Research, INC. Effiziente Synthese von Pyropheophorbid-A-Derivaten
US20040013561A1 (en) * 2002-07-18 2004-01-22 David Mann Methods for sterilizing recombinant or transgenic material
US20040126272A1 (en) * 2002-08-28 2004-07-01 Eric Bornstein Near infrared microbial elimination laser system
US20040156743A1 (en) * 2002-08-28 2004-08-12 Eric Bornstein Near infrared microbial elimination laser system
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
DE10324668A1 (de) * 2003-05-30 2004-12-23 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur extrakorporalen Bestrahlung einer Bilirubin enthaltenden Flüssigkeit und Verfahren hierfür
US20060269907A1 (en) * 2003-06-04 2006-11-30 American National Red Cross Decontamination of biological fluids using diphenylpyrilium compounds
WO2005025642A2 (en) * 2003-09-04 2005-03-24 Todd John Baumeister Device and method for irradiating blood
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB0414113D0 (en) * 2004-06-24 2004-07-28 Virulite Distrib Ltd Cosmetic uses of electromagnetic radiation
GB0512038D0 (en) * 2005-06-14 2005-07-20 Dougal Gordon Therapeutic and cosmetic uses of electromagnetic radiation
EP1779891A1 (de) * 2005-10-28 2007-05-02 Abdula Kurkayev Verfahren zum Aktivieren eines Photosensibilisators
DE102005062634A1 (de) 2005-12-23 2007-06-28 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
DE102005062410A1 (de) * 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
US20070197884A1 (en) * 2006-01-24 2007-08-23 Nomir Medical Technologies, Inc. Optical method and device for modulation of biochemical processes in adipose tissue
DE102006014184A1 (de) * 2006-03-24 2007-09-27 Heim, Heidrun Verfahren zum Inaktivieren von in Blutplasma unerwünschten Organismen, insbesondere von Viren
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
EP2008669A1 (de) * 2007-06-22 2008-12-31 Maco Pharma S.A. Bestrahlungsvorrichtung zur Deaktivierung von Krankheitserregern und/oder Leukozyten in einer biologischen Flüssigkeit und entsprechendes Verfahren
RU2010107157A (ru) * 2007-08-01 2011-09-10 Каридианбст Байотекнолоджиз, Ллс (Us) Инактивация патогенов цельной крови
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
GB0812753D0 (en) * 2008-07-14 2008-08-20 Dougal Gordon R P Electromagnetic radiation and its therapeutic effect
US20100120013A1 (en) * 2008-11-07 2010-05-13 Mb Research Laboratories, Inc. Procedure for long term corneal culture
WO2010141564A2 (en) * 2009-06-02 2010-12-09 Ceramoptec Industries, Inc. A novel method for microbial depletion in human blood and blood products using antimicrobial photodynamic therapy
US9011766B2 (en) 2012-11-19 2015-04-21 King Saud University Method for enhancing the shelf life of donor blood by laser biostimulation
US20150122738A1 (en) * 2013-11-05 2015-05-07 Angelo Gaitas Blood Cleansing System & Method
GB2525432A (en) 2014-04-24 2015-10-28 Univ Oslo Hf Modification of extracorporeal photopheresis technology with porphyrin precursors
JP2016146809A (ja) * 2015-02-13 2016-08-18 国立大学法人広島大学 ウイルス分離デバイス
WO2020017246A1 (ja) * 2018-07-17 2020-01-23 富士フイルム株式会社 光反応装置及び方法
US20210299257A1 (en) * 2020-03-25 2021-09-30 Mi2 Holdings LLC Methods, Systems and Apparatus for Reducing Pathogen Loads in Circulating Body Fluids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US405343A (en) † 1889-06-18 Combined nut and pipe wrench
EP0087441A1 (de) * 1981-09-08 1983-09-07 Quentron Optics Pty. Ltd. Photostrahlungsverfahren und anordnung
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
ATE59145T1 (de) † 1983-05-02 1991-01-15 Diamond Scient Co Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen.
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
FR2611141B1 (fr) * 1987-02-20 1991-02-01 Int Rech Cancer Centre Ensemble ou kit pour utilisation comme agent pour la destruction selective de cellules transformees ou tumorales
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5545516A (en) † 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
ATE214542T1 (de) † 1993-07-12 2002-04-15 Baxter Int Apparatur und verfahren zur inaktivierung von viralen verunreinigungen in körperflüssigkeit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107320743B (zh) * 2017-05-22 2020-09-18 鸿利智汇集团股份有限公司 一种利用移动终端实现紫外杀菌方法及系统

Also Published As

Publication number Publication date
CA1294411C (en) 1992-01-21
DE3855220D1 (de) 1996-05-23
EP0368902A1 (de) 1990-05-23
DE3855220T2 (de) 1996-11-14
AU2081988A (en) 1989-01-19
JP2930595B2 (ja) 1999-08-03
AU620556B2 (en) 1992-02-20
US5030200A (en) 1991-07-09
EP0368902B2 (de) 2001-03-28
EP0368902A4 (en) 1990-11-28
ATE136753T1 (de) 1996-05-15
WO1988010087A1 (en) 1988-12-29
EP0368902B1 (de) 1996-04-17
US4878891A (en) 1989-11-07
JPH03500531A (ja) 1991-02-07

Similar Documents

Publication Publication Date Title
DE3855220D1 (de) Methode zur beseitigung von infektionserregern in geweben
Baer The treatment of chronic osteomyelitis with the maggot (larva of the blow fly)
Baer The classic: the treatment of chronic osteomyelitis with the maggot (larva of the blow fly)
ES2180653T3 (es) Tratamiento de material biologico antes de la implantacion.
ES2130216T3 (es) Procedimiento de tratamiento de tejidos oseos y biomateriales implantables correspondientes.
ATE454166T1 (de) Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern
DE68918285D1 (de) Methode für behandlung von transplantaten vor transplantationen.
EP0443033A4 (en) Device for irradiating laser beams
ATE242960T1 (de) Vorrichtung und verfahren zur photoaktivierung
Baadsgaard et al. Muscle-pedicle bone grafts: an experimental study
ATE165008T1 (de) Methode zur behandlung intestinaler krankheiten
ES2053817T3 (es) Material de implante biologico reabsorbible asi como procedimiento para su fabricacion.
SE8800545D0 (sv) Alster och forfarande for processkontroll
DE3850655D1 (de) Verfahren zur Behandlung von Implantatmaterial und Implantat.
DE19543110A1 (de) Steriles Knochenmaterial nativen Ursprungs für die Transplantation und Verfahren zur Hitzesterilisierung des Knochenmaterials
SU1359795A1 (ru) Способ моделировани посттравматического остеомиелита
RU94013392A (ru) Способ скворцова получения вещества-носителя биоактивного излучения и устройство для облучения объекта биоактивной энергией
SU957911A1 (ru) Способ стерилизации аллотрансплантатов тканей
SU1641364A1 (ru) Способ стимул ции остеогенных свойств аутоспонгиозы
RU93048621A (ru) Способ устранения дефекта костной ткани
MD899G2 (ro) Procedeu de activizare a osteogenezei reparatorii
PARK et al. The treatment of infected non-union of fractures of long bones
YU24894A (sh) Čajna mešavina i postupak dobijanja čajnog ekstrakta za lečenje adnexitisa i steriliteta
GB809505A (en) Improvements in or relating to growth regulating compounds

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee